Before recommending peptide therapy, our providers may evaluate: Your health goals Current symptoms Injury or recovery concerns Medical history Medication and supplement use Sleep, stress, and lifestyle factors Mental health history Hormonal or metabolic concerns Lab testing when appropriate Safety risks and contraindications If peptide therapy is appropriate, your provider will explain the recommended approach, possible benefits, limitations, risks, and follow-up plan
IGF-1 LR3 has been chemically altered to have a much longer biological half-life
Theoretical concerns include growth factor-related effects in individuals with existing malignancies and immune modulation in vulnerable populations
We will cover your use of a medicine from the PDL as long as: The Agency for Health Care Administration (AHCA) also makes this information available
Signs your current concentration is too high If you are drawing fewer than 5 units per dose, your concentration may be too high for reliable measurement
Silent or painless Thyroiditis shows itself within the first year following birth, it is a condition of the thyroid gland related to lymphocytic inflammation
